Clinical Study
Left Atrial Appendage Management with the Watchman Device during Hybrid Ablation of Atrial Fibrillation
| | General characteristics | No (%), Mean ± SD or Median [IR] |
| | Male | 5 (50%) |
| | Age (years) | 65 ± 4 |
| | Body Mass Index (kg/m2) | 29.5 ± 6 |
| | CHA2DS2-VASc | 2 [2-3] |
| | AF characteristics | No (%) or Median [IR] |
| | Paroxysmal AF | 2 (20) |
| | Persistent AF | 7 (70) |
| | Long-standing persistent AF | 1 (10) |
| | Atrial Flutter | 3 (30) |
| | AF duration (months) | 33 [21-94] |
| | Echocardiography | No (%) or Mean ± SD |
| | Left ventricular ejection fraction (%) | 56 ± 8 |
| | LA size (mm), LA volume (mL), LA volume index | 47 ± 6, 99 ± 22, 50 ± 13 |
| | RA volume (mL) | 75 ± 31 |
| | Moderate to severe valvular disease | 0 |
|
|
SD = Standard Deviation, IR= interquartile range, AF = Atrial Fibrillation, OAC = Oral Anticoagulation, LA = Left Atrium, RA = right atrium.
|
